KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Baxter International (BAX) EBT (2016 - 2024)

Baxter International (BAX) has disclosed EBT for 16 consecutive years, with $959.0 million as the latest value for Q4 2024.

  • On a quarterly basis, EBT rose 64.49% to $959.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.1 billion, a 1197.11% increase, with the full-year FY2025 number at -$505.0 million, down 74.74% from a year prior.
  • EBT was $959.0 million for Q4 2024 at Baxter International, down from $1.0 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.0 billion in Q3 2024 to a low of -$3.0 billion in Q3 2022.
  • A 5-year average of $131.0 million and a median of $249.5 million in 2020 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 757.65% in 2022, then soared 728.57% in 2024.
  • Baxter International's EBT stood at $210.0 million in 2020, then tumbled by 137.14% to -$78.0 million in 2021, then crashed by 458.97% to -$436.0 million in 2022, then surged by 233.72% to $583.0 million in 2023, then surged by 64.49% to $959.0 million in 2024.
  • Per Business Quant, the three most recent readings for BAX's EBT are $959.0 million (Q4 2024), $1.0 billion (Q3 2024), and $1.0 billion (Q2 2024).